Transcenta Grants 451,500 Award Shares and 22,500 Options, Equal to 0.11% of Share Capital, to 145 Employees Including One Director

Bulletin Express
06/30

On 30 June 2026, Transcenta-B (Transcenta) approved two equity incentives under its 2022 Share Incentive Scheme: a grant of 451,500 award shares to 136 employees and a separate grant of 22,500 share options to nine employees.

Key terms of the award-share grant • Size: 451,500 shares, representing about 0.10 % of issued share capital (excluding treasury shares). • Participants: 135 employees (421,500 shares) and Non-executive Director Dr Hansen Xu (30,000 shares). • Cost to grantees: Nil purchase price and nil consideration. • Vesting: One- to four-year schedule for employees; three-year schedule for Dr Xu. • Pricing reference: HK$1.18 per share, the closing price on the grant date. • Performance targets: None. • Clawback: Unvested shares may be forfeited upon death, disability, redundancy or termination for cause; retirement vests as scheduled unless otherwise decided by the scheme administrator.

Key terms of the option grant • Size: 22,500 options, convertible into the same number of shares, equal to roughly 0.005 % of issued share capital. • Exercise price: HK$1.18, set at the highest of the grant-date close (HK$1.18), the prior five-day average close (HK$1.15) and par value. • Vesting: Fully vest one year after grant; exercisable within ten years, but not earlier than 12 months from the grant date. • Performance targets: None. • Clawback: Unvested options forfeit upon death or permanent disability, subject to administrator discretion.

Regulatory compliance • The 30,000 award shares for Dr Hansen Xu were approved by the independent non-executive directors in line with Rule 17.04(1) of the Listing Rules; Dr Xu abstained from voting. • No individual participant exceeds the 1 % single-participant limit, and no related-entity participants or service providers are included. • No financial assistance was provided for share purchases.

Scheme capacity After these grants, 926,990 shares remain available under both the overall scheme mandate limit and the service-provider sub-limit.

Rationale Management states the incentives are designed to retain key talent, align employee interests with shareholders and reward contributions to the Group’s long-term growth.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10